The interplay of glucagon-like peptide-1 receptor trafficking and signalling in pancreatic cells
Injection-site bruising, redness or a small itchy lump: 16.9% on cagrilintide vs 3.0% on placebo in REDEFINE 1, all mild, not dose-related
Other presentations, including Wegovy single-dose pens and many Mounjaro or Zepbound single-dose devices, cannot be click-counted at all
A new study suggests that individuals taking popular new GLP-1 receptor agonist drugs, such as Ozempic, Wegovy and Mounjaro, face an increased risk of nausea, vomiting and other stomach problems, especially when taking higher doses of the medication
It is advisable not to consume higher doses to avoid L-Carnitine side effects